February 26, 2018, 3:36 am
Facebook iconTwitter iconYouTube iconGoogle+ icon
1 Philippine Peso = 0.0709 UAE Dirham
1 Philippine Peso = 2.0666 Albanian Lek
1 Philippine Peso = 0.03436 Neth Antilles Guilder
1 Philippine Peso = 0.38512 Argentine Peso
1 Philippine Peso = 0.0246 Australian Dollar
1 Philippine Peso = 0.03436 Aruba Florin
1 Philippine Peso = 0.03861 Barbados Dollar
1 Philippine Peso = 1.59981 Bangladesh Taka
1 Philippine Peso = 0.0307 Bulgarian Lev
1 Philippine Peso = 0.00727 Bahraini Dinar
1 Philippine Peso = 33.8027 Burundi Franc
1 Philippine Peso = 0.01931 Bermuda Dollar
1 Philippine Peso = 0.02544 Brunei Dollar
1 Philippine Peso = 0.13243 Bolivian Boliviano
1 Philippine Peso = 0.06249 Brazilian Real
1 Philippine Peso = 0.01931 Bahamian Dollar
1 Philippine Peso = 1.24035 Bhutan Ngultrum
1 Philippine Peso = 0.18341 Botswana Pula
1 Philippine Peso = 386.48649 Belarus Ruble
1 Philippine Peso = 0.03857 Belize Dollar
1 Philippine Peso = 0.02437 Canadian Dollar
1 Philippine Peso = 0.01807 Swiss Franc
1 Philippine Peso = 11.38996 Chilean Peso
1 Philippine Peso = 0.12225 Chinese Yuan
1 Philippine Peso = 54.88417 Colombian Peso
1 Philippine Peso = 10.92317 Costa Rica Colon
1 Philippine Peso = 0.01931 Cuban Peso
1 Philippine Peso = 1.73147 Cape Verde Escudo
1 Philippine Peso = 0.39788 Czech Koruna
1 Philippine Peso = 3.41371 Djibouti Franc
1 Philippine Peso = 0.11689 Danish Krone
1 Philippine Peso = 0.94363 Dominican Peso
1 Philippine Peso = 2.19764 Algerian Dinar
1 Philippine Peso = 0.24563 Estonian Kroon
1 Philippine Peso = 0.34054 Egyptian Pound
1 Philippine Peso = 0.5251 Ethiopian Birr
1 Philippine Peso = 0.0157 Euro
1 Philippine Peso = 0.03853 Fiji Dollar
1 Philippine Peso = 0.01381 Falkland Islands Pound
1 Philippine Peso = 0.01382 British Pound
1 Philippine Peso = 0.08607 Ghanaian Cedi
1 Philippine Peso = 0.90347 Gambian Dalasi
1 Philippine Peso = 173.55213 Guinea Franc
1 Philippine Peso = 0.14162 Guatemala Quetzal
1 Philippine Peso = 3.93494 Guyana Dollar
1 Philippine Peso = 0.15101 Hong Kong Dollar
1 Philippine Peso = 0.45448 Honduras Lempira
1 Philippine Peso = 0.11653 Croatian Kuna
1 Philippine Peso = 1.23243 Haiti Gourde
1 Philippine Peso = 4.90965 Hungarian Forint
1 Philippine Peso = 263.76448 Indonesian Rupiah
1 Philippine Peso = 0.06723 Israeli Shekel
1 Philippine Peso = 1.25268 Indian Rupee
1 Philippine Peso = 22.85714 Iraqi Dinar
1 Philippine Peso = 718.33978 Iran Rial
1 Philippine Peso = 1.93822 Iceland Krona
1 Philippine Peso = 2.4222 Jamaican Dollar
1 Philippine Peso = 0.01364 Jordanian Dinar
1 Philippine Peso = 2.0617 Japanese Yen
1 Philippine Peso = 1.96236 Kenyan Shilling
1 Philippine Peso = 1.311 Kyrgyzstan Som
1 Philippine Peso = 76.94981 Cambodia Riel
1 Philippine Peso = 7.70077 Comoros Franc
1 Philippine Peso = 17.37452 North Korean Won
1 Philippine Peso = 20.76255 Korean Won
1 Philippine Peso = 0.00578 Kuwaiti Dinar
1 Philippine Peso = 0.01583 Cayman Islands Dollar
1 Philippine Peso = 6.1749 Kazakhstan Tenge
1 Philippine Peso = 159.87839 Lao Kip
1 Philippine Peso = 29.06178 Lebanese Pound
1 Philippine Peso = 2.99421 Sri Lanka Rupee
1 Philippine Peso = 2.50386 Liberian Dollar
1 Philippine Peso = 0.22268 Lesotho Loti
1 Philippine Peso = 0.05886 Lithuanian Lita
1 Philippine Peso = 0.01198 Latvian Lat
1 Philippine Peso = 0.0257 Libyan Dinar
1 Philippine Peso = 0.1777 Moroccan Dirham
1 Philippine Peso = 0.32037 Moldovan Leu
1 Philippine Peso = 0.96332 Macedonian Denar
1 Philippine Peso = 25.79151 Myanmar Kyat
1 Philippine Peso = 46.1583 Mongolian Tugrik
1 Philippine Peso = 0.15547 Macau Pataca
1 Philippine Peso = 6.75676 Mauritania Ougulya
1 Philippine Peso = 0.63514 Mauritius Rupee
1 Philippine Peso = 0.29614 Maldives Rufiyaa
1 Philippine Peso = 13.77317 Malawi Kwacha
1 Philippine Peso = 0.35764 Mexican Peso
1 Philippine Peso = 0.07562 Malaysian Ringgit
1 Philippine Peso = 0.22261 Namibian Dollar
1 Philippine Peso = 6.9112 Nigerian Naira
1 Philippine Peso = 0.59556 Nicaragua Cordoba
1 Philippine Peso = 0.15133 Norwegian Krone
1 Philippine Peso = 1.99853 Nepalese Rupee
1 Philippine Peso = 0.02647 New Zealand Dollar
1 Philippine Peso = 0.00743 Omani Rial
1 Philippine Peso = 0.01931 Panama Balboa
1 Philippine Peso = 0.06266 Peruvian Nuevo Sol
1 Philippine Peso = 0.06071 Papua New Guinea Kina
1 Philippine Peso = 1 Philippine Peso
1 Philippine Peso = 2.13127 Pakistani Rupee
1 Philippine Peso = 0.06552 Polish Zloty
1 Philippine Peso = 107.39382 Paraguayan Guarani
1 Philippine Peso = 0.07027 Qatar Rial
1 Philippine Peso = 0.07302 Romanian New Leu
1 Philippine Peso = 1.08832 Russian Rouble
1 Philippine Peso = 16.23803 Rwanda Franc
1 Philippine Peso = 0.07239 Saudi Arabian Riyal
1 Philippine Peso = 0.14989 Solomon Islands Dollar
1 Philippine Peso = 0.25792 Seychelles Rupee
1 Philippine Peso = 0.34575 Sudanese Pound
1 Philippine Peso = 0.15762 Swedish Krona
1 Philippine Peso = 0.02545 Singapore Dollar
1 Philippine Peso = 0.01382 St Helena Pound
1 Philippine Peso = 0.42869 Slovak Koruna
1 Philippine Peso = 147.2973 Sierra Leone Leone
1 Philippine Peso = 10.84942 Somali Shilling
1 Philippine Peso = 384.74904 Sao Tome Dobra
1 Philippine Peso = 0.16892 El Salvador Colon
1 Philippine Peso = 9.9417 Syrian Pound
1 Philippine Peso = 0.22262 Swaziland Lilageni
1 Philippine Peso = 0.60579 Thai Baht
1 Philippine Peso = 0.04633 Tunisian Dinar
1 Philippine Peso = 0.04271 Tongan paʻanga
1 Philippine Peso = 0.07317 Turkish Lira
1 Philippine Peso = 0.12974 Trinidad Tobago Dollar
1 Philippine Peso = 0.56444 Taiwan Dollar
1 Philippine Peso = 43.35907 Tanzanian Shilling
1 Philippine Peso = 0.52008 Ukraine Hryvnia
1 Philippine Peso = 70.40541 Ugandan Shilling
1 Philippine Peso = 0.01931 United States Dollar
1 Philippine Peso = 0.54923 Uruguayan New Peso
1 Philippine Peso = 157.72201 Uzbekistan Sum
1 Philippine Peso = 558.39769 Venezuelan Bolivar
1 Philippine Peso = 438.97684 Vietnam Dong
1 Philippine Peso = 2.05502 Vanuatu Vatu
1 Philippine Peso = 0.04818 Samoa Tala
1 Philippine Peso = 10.28822 CFA Franc (BEAC)
1 Philippine Peso = 0.05212 East Caribbean Dollar
1 Philippine Peso = 10.28822 CFA Franc (BCEAO)
1 Philippine Peso = 1.87297 Pacific Franc
1 Philippine Peso = 4.82336 Yemen Riyal
1 Philippine Peso = 0.22278 South African Rand
1 Philippine Peso = 100.1834 Zambian Kwacha
1 Philippine Peso = 6.98649 Zimbabwe dollar

Sale of dengue vaccine suspended

THE Food and Drug Administration (FDA) yesterday suspended the sale of controversial dengue vaccine Dengvaxia and ordered its withdrawal from the market.

This as government assured that people will be held accountable for the mess created by the dengue vaccine that was provided to more than 730,000 children through the government’s mass immunization program.

The FDA, in its Advisory No. 2017-318, ordered vaccine manufacturer Sanofi Pasteur, Inc., “to suspend the sale/distribution/marketing of Dengvaxia and cause the withdrawal of Dengvaxia in the market pending compliance with the directives of the FDA.”

The agency said the order is in response to the latest advisory issued by Sanofi regarding the potential adverse effect of the dengue vaccine.

“The advisory contained information on the completion of a post-clinical trial study of the said product indicating potential risk to patients who have not had dengue prior to immunization,” said FDA.

The World Health Organization supported the Philippines’ suspension of dengue vaccinations.

In a statement, the WHO said: “Like many others in the Philippines, WHO is awaiting the expert analysis of new data and advice about its implications for use of the vaccine. In the meantime, WHO supports the Philippines Department of Health’s (DOH) decision to suspend the ongoing vaccination program until more information is available. This is appropriate in the circumstances,” it said.

Health Secretary Francisco Duque III said there will be an extensive probe on who should be held liable for the erroneous dengue vaccine program given the latest advisory issued by its manufacturer.

“Once it is proven that there were information that were not fully disclosed but were factors in these latest developments, someone will surely be held accountable,” said Duque in a radio interview.

“There will be cases filed,” he added.

Duque said DOH legal services is going through the DOH-Sanofi contract to see if there are any legal implications of the controversy.

The National Bureau of Investigation has been ordered to probe the dengue vaccine controversy.

Duque said private individuals also have the option to file class suits against individuals whom they believe should be held liable.

“I heard there were already those planning to file class suits in behalf of the children, who have been vaccinated and their worried parents,” he said.

REFUND?

Duque said the DOH could also push for a refund of the P3.5 billion public funds spent in procuring the dengue vaccines from Sanofi.

He said DOH has a stockpile of about P1.4 billion worth of dengue vaccines.

The vaccines, which are stored at the Research Institute for Tropical Medicine, are set to expire between 2018 and 2019.

Senate President pro tempore Ralph Recto said the DOH could demand a refund, citing the Government Procurement Law, or Republic Act 9184.

“RA 9184 has an anti-lemon provision. It is discussed extensively in Section 62, which deals with faulty, defective substandard goods and services. The bottomline is that the government is entitled to restitution,” Recto said.

“In fact, RA 9184 requires the supplier to post [a] ‘retention money’, which the government shall hold on to until the warranty has lapsed, to ensure that goods supplied are free from defects,” he added.

Recto said this is a standard clause in all government contracts.

“Kung wala ito sa kontrata sa pagbili ng bakuna, may natulog sa pansitan.”

If the supplier ignores the demand, Recto said section 65 says “that its properties shall be subject to attachment or garnishment proceedings to recover the costs.”

Recto noted that many corporations have been paying huge fines upon orders of regulatory bodies, “a path Sanofi should follow if it wants to retain public goodwill.”

“Uber, Metrobank, RCBC, PAL are some of the companies which have willingly paid a fine, or settled obligations, for operational oversights committed,” he said.

SYMPTOMS

Duque, meanwhile, raised doubts on claims made by Sanofi that having “severe” cases of dengue are not as bad as the public’s belief.

He noted how the picture painted by the pharmaceutical firm is under a controlled environment.

“Sanofi’s definition of severe is under controlled circumstances, which are under their close supervision.

But that is different from what is happening on the ground, from reality, from those that are in far-flung areas. Of course they cannot supervise everyone,” stressed Duque.

According to Sanofi officials, the severe case they have been referring to are only fever of two days, having bruises, and nose bleeding.

Duque also said they cannot just disregard the remaining 10 percent, who were given vaccines but have not had dengue, therefore has the chance of being afflicted with a “severe dengue case.”

The Department of Education said it has not received any report of untoward reactions to Dengvaxia dengue vaccine from public school students.

Education Secretary Leonor Briones said: “We are looking into the breakdown on whether these 700,000 are all students or if they are from the communities and adults because the DOH itself has its own health programs wherein this vaccine was also utilized, so we want to look at that.”

“We need to inform the parents, further inform the parents of the situation. They have to help us monitor the children because we, the children are only under our care during weekdays, during school time,” she said. – With Evan Orias, JP Lopez, Jocelyn Montemayor and Reuters
 
Category: 
Rating: 
No votes yet

Column of the Day

Is democracy in recession?

By JOSE BAYANI BAYLON | February 26,2018
‘Populists tend to deny the legitimacy of established parties, attacking them as undemocratic and even unpatriotic.’

Opinion of the Day

New, better dengue vaccines

By DAHLI ASPILLERA | February 26, 2018
‘Sanofi’s setbacks from its rush to market; careless oversights, could lead to better future dengue vaccines from other pharmaceuticals.’